Position in GILD
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$1,479,188
-$144,472 QoQ
Shares Held
11,708
+0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#936
of 2,275 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rehmann Capital Advisory Group holds $37,318,224 across 12 Drug Manufacturers - General names. GILD ranks #9 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,703 | $9,829,400 | |
| 2 | LLY |
ELI LILLY & Co
|
5,246 | $6,292,210 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,611 | $3,805,013 | |
| 4 | PFE |
Pfizer Inc
|
152,066 | $3,661,749 | |
| 5 | ABBV |
AbbVie Inc.
|
12,987 | $3,268,048 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,344 | $2,439,861 | |
| 7 | AMGN |
Amgen Inc
|
6,083 | $2,202,775 | |
| 8 | AZN |
Astrazeneca PLC
|
10,283 | $1,949,862 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,479,188 | 11,708 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $1,623,660 | 11,650 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,386,225 | 11,294 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $1,158,951 | 10,441 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $1,128,679 | 10,073 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $922,961 | 9,992 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $807,043 | 9,626 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $637,592 | 9,293 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $762,532 | 10,410 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,009,222 | 12,458 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $899,879 | 12,008 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $980,715 | 12,725 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $1,049,487 | 12,649 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,079,220 | 12,571 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $766,683 | 12,428 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $706,426 | 11,429 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $551,220 | 9,272 | Shares | Sole | 2022-06-03 | |
| 2021-12-31 | $840,242 | 11,572 | Shares | Sole | 2022-03-02 | |
| 2021-09-30 | $774,217 | 11,084 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $851,178 | 12,361 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $771,552 | 11,938 | Shares | Sole | 2021-05-26 | |
| 2020-12-31 | $724,812 | 12,441 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $1,504,933 | 23,816 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $1,045,537 | 13,589 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $949,601 | 12,702 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||